Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Melinda Vassallo"'
Autor:
Judith D Goldberg, Joseph Markowitz, Jeffrey Weber, Ragini Kudchadkar, Tomas Kirchhoff, Anna Pavlick, Zeynep Eroglu, Melinda Vassallo, David M Woods, Andrew S Brohl, Nikhil I Khushalani, Alison Richards, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background Adjuvant therapy for high-risk resected melanoma with programmed cell-death 1 blockade results in a median relapse-free survival (RFS) of 5 years. The addition of low dose ipilimumab (IPI) to a regimen of adjuvant nivolumab (NIVO) in Check
Externí odkaz:
https://doaj.org/article/1c7d034388cd4ebbbabd2100271c621e
Autor:
Tatsuya Yoshida, Junya Ichikawa, Iulia Giuroiu, Andressa S Laino, Yuhan Hao, Melinda Vassallo, David M Woods
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundHigh C reactive protein (CRP) levels have been reported to be associated with a poor clinical outcome in a number of malignancies and with programmed cell death protein 1 immune checkpoint blockade in patients with advanced cancer. Little i
Externí odkaz:
https://doaj.org/article/aae5fb414af742819dd542c979601775
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Inflammatory mediators, including acute phase reactants and cytokines, have been reported to be associated with clinical efficacy in patients with melanoma and other cancers receiving immune checkpoint inhibitors (ICI). Analyses of patient
Externí odkaz:
https://doaj.org/article/7cfe45910c204b928110a2582097e79b
Autor:
Jeffrey S. Weber, Jonathan P. Schneck, Kristi Jones, Mathias Oelke, Sojung Kim, David Woods, Melinda Vassallo, Andressa S. Laino, Ariel Isser, Tatsuya Yoshida, Junya Ichikawa
Purpose:Generation of antigen-specific T cells from patients with cancer employs large numbers of peripheral blood cells and/or tumor-infiltrating cells to generate antigen-presenting and effector cells commonly requiring multiple rounds of restimula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::225159bde52db6701a2d2eaa3f9d559c
https://doi.org/10.1158/1078-0432.c.6529425.v1
https://doi.org/10.1158/1078-0432.c.6529425.v1
Autor:
Jeffrey S. Weber, Jonathan P. Schneck, Kristi Jones, Mathias Oelke, Sojung Kim, David Woods, Melinda Vassallo, Andressa S. Laino, Ariel Isser, Tatsuya Yoshida, Junya Ichikawa
Polyfunctional analysis of MART-1 Tet+ CD8+ T-cells expanded by nano-aAPC or DCs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ef9d500168ea7bd648a905d8eba3b5
https://doi.org/10.1158/1078-0432.22476573.v1
https://doi.org/10.1158/1078-0432.22476573.v1
Autor:
Nikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, Zeynep Eroglu, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Tomas Kirchhoff, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney, Ragini Kudchadkar, Joseph Markowitz, Andrew S Brohl, Anna Pavlick, Alison Richards, David M Woods, Jeffrey Weber
Publikováno v:
Journal for immunotherapy of cancer. 10(11)
BackgroundAdjuvant therapy for high-risk resected melanoma with programmed cell-death 1 blockade results in a median relapse-free survival (RFS) of 5 years. The addition of low dose ipilimumab (IPI) to a regimen of adjuvant nivolumab (NIVO) in CheckM
Autor:
Melinda Vassallo, Jonathan P. Schneck, Tatsuya Yoshida, Jeffrey S. Weber, David M. Woods, Ariel Isser, Sojung Kim, Jones Kristi, Andressa S. Laino, Mathias Oelke, Junya Ichikawa
Publikováno v:
Clin Cancer Res
Purpose: Generation of antigen-specific T cells from patients with cancer employs large numbers of peripheral blood cells and/or tumor-infiltrating cells to generate antigen-presenting and effector cells commonly requiring multiple rounds of restimul
Autor:
Emily Monk, Pratip K. Chattopadhyay, Paulo Burke, David M. Woods, Melinda Vassallo, Jeffrey S. Weber
Signal transducer and activator of transcription (STAT) proteins are a family of transcription factors controlling functions in immune responses and other cell types. Given their importance, we developed a flow cytometry panel to assess eight phospho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b85ed601d6fc45ae51ce9a1e0bcd038
https://doi.org/10.1101/2021.11.22.469156
https://doi.org/10.1101/2021.11.22.469156
Autor:
David M. Woods, Melinda Vassallo, Michelle Krogsgaard, Tatsuya Yoshida, Junya Ichikawa, Jeffrey S. Weber, Yuhan Hao, F. Stephen Hodi, Andressa S. Laino, Iulia Giuroiu
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundHigh C reactive protein (CRP) levels have been reported to be associated with a poor clinical outcome in a number of malignancies and with programmed cell death protein 1 immune checkpoint blockade in patients with advanced cancer. Little i
Publikováno v:
Cancer Research. 80:PO-007
While immune checkpoint inhibitor (CPI) therapies have revolutionized the treatment of metastatic melanoma and other malignancies, many patients fail to respond, necessitating to explore combination therapies to improve response rates. Histone deacet